Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity

Cell Stress and Chaperones

Volumn 9, Issue 2, 2004, Pages 150-166

  Manero, Florence ^a   Ljubic Thibal, Vesna ^a,b   Moulin, Maryline ^a   Goutagny, Nadège ^c   Yvin, Jean Claude ^b   Arrigo, André Patrick ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Laboratoires Goemar   (France)

^c BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELL SURFACE RECEPTOR; DEXTRAN SULFATE; DODECYL SULFATE SODIUM; FAS ANTIBODY; FAS LIGAND; FAS RECEPTOR; HEAT SHOCK PROTEIN 27; HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; IMMUNOGLOBULIN M ANTIBODY; POLYSACCHARIDE SULFATE; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DEXTRAN SULFATE; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HELA CELLS; HEPARIN; HEPARITIN SULFATE; HSP20 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; MICE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 3543043780     PISSN: 13558145     EISSN: None     Source Type: Journal    
DOI: 10.1379/CSC-16R.1     Document Type: Article

References (63)

1. Arase H, Arase N, Saito T. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181: 1235-1238.
2. Aronis A, Melendez JA, Golan O, Shilo S, Dicter N, Tirosh O. 2003. Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Cell Death Differ 10: 335-344.
3. Bando M, Miyake Y, Shiina M, Wachi M, Nagai K, Kataoka T. 2002. Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells. Biochem Biophys Res Commun 290: 268-274.
4. Biancone L, Martino AD, Orlandi V, Conaldi PG, Toniolo A, Camussi G. 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J Exp Med 186: 147-152.
5. Bjork I, Lindahl U. 1982. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 48: 161-182.
6. Bonnotte B, Favre N, Reveneau S, et al. 1998. Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death Differ 5: 480-487.
7. Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES, Cohen GM. 2001. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J 20: 998-1009.
8. Bruey JM, Ducasse C, Bonniaud P, et al. 2000. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2: 645-652.
9. Caricchio R, D'Adamio L, Cohen PL. 2002. Fas, ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line. Cell Death Differ 9: 574-580.
10. Charette SJ, Lavoie JN, Lambert H, Landry J. 2000. Inhibition of daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20: 7602-7612.
11. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
12. Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, Fuks Z, Gulbins E, Kolesnick R. 2001. Ceramide enables fas to cap and kill. J Biol Chem 276: 23954-23961.
13. Erduran E, Tekelioglu Y, Gedik Y, Yildiran A. 1999. Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study. Am J Hematol 61: 90-93.
14. Fadeel B, Lindberg J, Achour A, Chiodi F. 1998. A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Int Immunol 10: 131-140.
15. Favre D, Berthillon P, Trepo C. 2001. Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. C R Acad Sci III 324: 1141-1148.
16. Fleisher TA, Straus SE, Bleesing JJ. 2001. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome. Curr Allergy Asthma Rep 1: 534-540.
17. Fulda S, Meyer E, Debatin KM. 2000. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 60: 3947-3956.
18. Goldman FD, Vibhakar R, Puck JM, et al. 2002. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome. Clin Immunol 104: 31-39.
19. Gorski A, Wasik M, Nowaczyk M, Korczak-Kowalska G. 1991. Immunomodulating activity of heparin. FASEB J 5: 2287-2291.
20. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E. 2001. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276: 20589-20596.
21. Hanabuchi S, Koyanagi M, Kawasaki A, et al. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 91: 4930-4934.
22. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE. 2000. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J 19: 5418-5428.
23. Huang DC, Hahne M, Schroeter M, et al. 1999. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci U S A 96: 14871-14876.
24. Ishikawa Y, Kitamura M. 1999. Inhibition of glomerular cell apoptosis by heparin. Kidney Int 56: 954-963.
25. Itoh N, Yonehara S, Ishii A, et al. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
26. Kagi D, Vignaux F, Ledermarm B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528-530.
27. Kamitani T, Nguyen HP, Yeh ET. 1997. Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodies. J Biol Chem 272: 22307-22314.
28. Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y, Tasaka K. 2000. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. Int J Cancer 88: 986-991.
29. Kischkel FC, Hellbardt S, Behrmarm I, Germer M, Pawlita M, Krammer PH, Peter ME. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588.
30. Kulms D, Dussmann H, Poppelmann B, Stander S, Schwarz A, Schwarz T. 2002. Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1). Cell Death Differ 9: 598-608.
31. Lee Y, Shacter E. 2001. Fas aggregation does not correlate with Fas-mediated apoptosis. J Immunol 167: 82-89.
32. Lowin B, Hahne M, Mattmann C, Tschopp J. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 650-652.
33. Mehlen P, Préville X, Chareyron P, Briolay J, Klemenz R, Arrigo A-P. 1995. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 154: 363-374.
34. Mehlen P, Schulze-Osthoff K, Arrigo AP. 1996. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271: 16510-16514.
35. Mounier N, Arrigo AP. 2002. Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones 7: 167-176.
36. Muzio M, Chinnaiyan AM, Kischkel FC, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827.
37. Nagata S. 1997. Apoptosis by death factor. Cell 88: 355-365.
38. Nagata S, Golstein P. 1995. The Fas death factor. Science 267: 1449-1456.
39. Nitobe J, Yamaguchi S, Okuyama M, et al. 2003. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res 57: 119-128.
40. Owen-Schaub LB. 2002. Fas function and tumor progression: use it and lose it. Cancer Cell 2: 95-96.
41. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. 1994. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 54: 1580-1586.
42. Pandey P, Farber R, Nakazawa A, et al. 2000. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19: 1975-1981.
43. Parish CR, Rylatt DB, Snowden JM. 1984. Demonstration of lymphocyte surface lectins that recognize sulphated polysaccharides. J Cell Sci 67: 145-158.
44. Parish CR, Snowden JM. 1985. Lymphocytes express a diverse array of specific receptors for sulfated polysaccharides. Cell Immunol 91: 201-214.
45. Parlato S, Giammarioli AM, Logozzi M, et al. 2000. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J 19: 5123-5134.
46. Paul C, Arrigo AP. 2000. Comparison of the protective activities generated by two survival proteins: Bcl-2 and Hsp27 in L929 murine fibroblasts exposed to menadione or staurosporine. Exp Gerontol 35: 757-766.
47. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. 2002. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 22: 816-834.
48. Rane MJ, Pan Y, Singh S, et al. 2003. Heat shock protein 27 controls apoptosis by regulating akt activation. J Biol Chem 278: 27828-27835.
49. Ricci-Vitiani L, Conticello C, Zeuner A, De Maria R. 2000. CD95/ CD95L interactions and their role in autoimmunity. Apoptosis 5: 419-424.
50. Rifkin IR, Marshak-Rothstein A. 1999. Fas and Fas ligand in autoimmunity. Curr Dir Autoimmun 1: 31-55.
51. Rothberg KG, Ying YS, Kamen BA, Anderson RG. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 111: 2931-2938.
52. Samali A, Robertson JD, Peterson E, et al. 2001. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones 6: 49-58.
53. Scaffidi C, Fulda S, Srinivasan A, et al. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
54. Schulze-Osthoff K, Krammer PH, Droge W. 1994. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13: 4587-4596.
55. Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM. 2002. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 277: 11345-11351.
56. Tellam RL, Parish CR. 1987. The effect of sulfated polysaccharides on the free intracellular calcium ion concentration of lymphocytes. Biochim Biophys Acta 930: 55-64.
57. Thome M, Tschopp J. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 1: 50-58.
58. Thurn AL, Underhill CB. 1986. Heparin-induced aggregation of lymphoid cells. J Cell Physiol 126: 352-358.
59. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE. 2001. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276: 16484-16490.
60. Turnbull J, Powell A, Guimond S. 2001. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11: 75-82.
61. Tyrell DJ, Kilfeather S, Page CP. 1995. Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol Sci 16: 198-204.
62. Verhagen AM, Ekert PG, Pakusch M, et al. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53.
63. Zou H, Li Y, Liu X, Wang X. 1999. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274: 11549-11556.